Lactic Acid
In clinical developmentAlso known as 2-Hydroxypropanoic acid, 2-Hydroxypropionic acid, 4XLA Activator, Acidum lacticum+31 more
2-Hydroxypropanoic acid, 2-Hydroxypropionic acid, 4XLA Activator, Acidum lacticum, Amlactin, Astri-UC, Atrac-Tain, Dermaplex, Geri-Hydrolac, Ionosol-MB, LACTIC ACID, UNSPECIFIED FORM, Lac-Hydrin, Laclotion, Lacticare, Lacticum acidum, Lactinol, Milchsäure, Milk acid, Oxy Gard, Penederm, Phexx, Phexxi, Pur-Oxy, SLT, U-Lactin, Valiant Barrier, Valiant Shield, ácido láctico, Lactic Acid 10%, Dianeal Low Calcium 1.5, Dianeal Low Calcium 2.5, Dianeal Low Calcium 4.25, Dianeal PD-2/1.5, Dianeal PD-2/2.5, Dianeal PD-2/4.25.
Recent clinical, regulatory, research and industry developments relating to this drug.
Role of Histone Lactylation in Neurological Disorders.
Lactate and lactylation in cancer.
Lactate controls cancer stemness and plasticity through epigenetic regulation.
From metabolic byproduct to immune modulator: the role of lactate in tumor immune escape.
Lactate's impact on immune cells in sepsis: unraveling the complex interplay.
Profile
Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.
Clinical trials
The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.
Late-stage studies
Phase III+ trials still open or recently active — where late-stage evidence is being generated.
Recent completions
Trials that read out recently, adding to the completed evidence base.
Research activity
Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.
Major research themes8
Journals, researchers & institutions
- International journal of molecular sciences4
- Nature communications3
- Frontiers in immunology2
- Signal transduction and targeted therapy2
- Autophagy1
- Blood1
- Wang X3
- Alhazzani W2
- Chen L2
- Magistretti PJ2
- Pellerin L2
- Wang W2
- Wang Z2
- Wu X2
- McMaster University2
- Advocate Children's Hospital1
- All India Institute of Medical Sciences1
- Apollo Hospitals1
- ASAN Medical Center1
- Australian and New Zealand Intensive Care Research Centre1
Related diseases
Regulator-approved indications and conditions co-mentioned with this drug across the research literature. Number shows shared papers.
Related drugs
Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).
Studied across 6 of the same disease areas as Lactic Acid in the shared literature.
Studied across 6 of the same disease areas as Lactic Acid in the shared literature.
Studied across 3 of the same disease areas as Lactic Acid in the shared literature.
Studied across 2 of the same disease areas as Lactic Acid in the shared literature.
- RxNorm (U.S. National Library of Medicine) — drug identity
- ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
- Europe PMC — research literature
- ClinicalTrials.gov — clinical trials